Pentwater Capital Management LP Spring Works Therapeutics, Inc. Transaction History
Pentwater Capital Management LP
- $15.9 Billion
- Q3 2025
Shares
2 transactions
Others Institutions Holding SWTX
# of Institutions
26Shares Held
7.39MCall Options Held
23KPut Options Held
11-
Black Rock Inc. New York, NY5.62MShares$264 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V81.06MShares$49.9 Million0.03% of portfolio
-
Eagle Asset Management Inc St Petersburg, FL273KShares$12.9 Million0.05% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL184KShares$8.63 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V859.2KShares$2.78 Million0.0% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.93B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...